Holding the Line in AML: Real-World Care Meets Breakthrough Trials
The HemOnc Pulse
00:00
COMET-001 trial design
Eunice Wang outlines the COMET-001 phase 1/2 study testing ziftomenib in heavily pretreated NPM1-mutant AML.
Play episode from 02:59
Transcript
